Mega Mergers in the West. The Rationale behind the Recent Mega Merger Activity between Western Pharmaceutical Companies.
-
- FERGUSON Michael
- Pharmaceutical analyst at Wood Mackenzie (a division of Deutsche Bank AG), based in Kintore House
書誌事項
- タイトル別名
-
- The Rationale behind the Recent Mega Merger Activity between Western Pharmaceutical Companies
この論文をさがす
抄録
The aim of this article is to provide an overview of mega-merger activity in western pharmaceutical markets and the reasons for it, and also to explain why we believe mega-merger activity will likely continue in the future. We will also consider a fictitious mega-merged Japanese company and where it would fit in the global pharmaceutical market.
収録刊行物
-
- 薬学図書館
-
薬学図書館 46 (4), 341-347, 2001
日本薬学図書館協議会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204276868864
-
- NII論文ID
- 130004066278
- 40003663244
-
- NII書誌ID
- AN00241547
-
- ISSN
- 2186070X
- 03862062
-
- NDL書誌ID
- 5978455
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可